Serum and urinary beta 2-microglobulin levels in gravida with chronic glomerulonephritis and pure toxemia of pregnancy. 1987

Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata

UI MeSH Term Description Entries
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin

Related Publications

Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
August 1985, Orvosi hetilap,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
January 1992, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
January 1988, European urology,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
July 1948, American journal of obstetrics and gynecology,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
January 1989, Clinical and laboratory haematology,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
September 1991, Clinica chimica acta; international journal of clinical chemistry,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
May 1988, Revista espanola de las enfermedades del aparato digestivo,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
January 1997, American journal of obstetrics and gynecology,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
May 1979, The Journal of urology,
Y Nagai, and T Suzuki, and T Fushimi, and M Maeda, and S Kawamura, and K Hirata
January 1985, Harefuah,
Copied contents to your clipboard!